Pancreatic cancer is the fourth common cause of cancer death, and its 5-year survival rate is only about 12% despite the advancement in medical care, chemotherapy, radiotherapy, and molecular biology. The pancreatoduodenectomy, also known as the Whipple procedure, is the surgical procedure of choice for the resectable and the borderline resectable pancreatic ductal adenocarcinomas.[1] This surgical procedure poses immense difficulties to the surgeons due to the complex as well as highly difficult intra-abdominal dissection and likewise the repair of the digestion system.[1] Due to its complex nature, this procedure has historically been associated with higher mortality and perioperative morbidity.[1]
Historically, the first pancreaticoduodenectomy was performed by Dr. Alessandro Codivilla, an Italian surgeon, in 1898 and was later modified by Dr. Walter Kausch in 1912. The surgery was then performed as a two-stage procedure, and Dr. Allen Whipple further improved it into a one-stage Whipple procedure in 1940.[2][3] Later on, it was established that this procedure is associated with a high mortality rate; however, with improving medical knowledge and surgical advancement, there has been a significant drop in mortality. With an experienced surgeon in high-load hospitals, the mortality rate drops to about 3% to 5%.[4]
Broadly, there are two types of pancreatoduodenectomies; the more extensive "classical Whipple (CW)" and the "pylorus sparing pancreatoduodenectomy (PSD)." [5] The CW entails the removal of the pancreatic head, the duodenum, a section of the stomach, the gallbladder, and a part of the bile duct while in the PSD the part of the stomach is spared.
Moreover, the pancreaticoduodenectomy can be performed using the laparoscopic, as well as the open approach.[6] Although, the recent data related to the feasibility and the shorter postoperative outcomes following both open and laparoscopic approaches for pancreatoduodenectomy have suggested that the laparoscopic approach is associated with shorter length of stay, less blood loss, and better lymph node dissection.[6] However, the physicians around the globe are still hesitating in the global adaptation of the laparoscopic strategy, which may be most likely as a result of the highly challenging dissection and the anastomosis in this procedure. Also, the oncological end results following the open and laparoscopic strategy for pancreatoduodenectomy are still vague and even questionable.[7]
This article describes in detail the surgical anatomy, indications, contraindications, technical steps in the pancreaticoduodenectomy, and its clinical significance.
The pancreas is a retroperitoneal organ and located within the C-loop of the duodenum. It is divided into the head, uncinate process, neck, body, and tail. The head and the uncinate process are supplied by superior and inferior pancreaticoduodenal arteries, which are branches from the gastroduodenal artery and middle colic artery. The neck, body, and tail of the pancreas receive blood supply from the splenic artery through the dorsal pancreatic artery, greater pancreatic artery, and transverse pancreatic artery. The head of the pancreas is primarily drained by the four pancreaticoduodenal veins, whereas they drain into the superior mesenteric vein (SMV) or portal vein (PV). The neck, body, and tail of the pancreas have venous drainage into the splenic vein. The main duct of the pancreas (Wirsung) begins in the tail, runs the entire length of the pancreas, and opens into the second part of the duodenum together with the bile duct on the major duodenal papilla.
There are several critical anatomical considerations in pancreatic surgery. The pancreas shares the same blood supply with the C-loop of the duodenum, necessitating the removal of the C-loop of the duodenum together with the pancreas. The uncinate process which arises from the lower part of the head of the pancreas extends superiorly and posteriorly behind the superior mesenteric vein (SMV) is recognized as essential surgical anatomy.[8] Tumor involving the uncinate process is associated with vascular invasion and poor prognosis compared with non-uncinate process pancreas cancer.[9]
Variation in vascular anatomy in this region is uncommon compared to biliary variation; however, there is some relevant variation that needs to be borne in mind. Replaced right hepatic artery arising from the superior mesenteric artery occurs around 12% of the population.[10] In this case, the native hepatic artery is absent. The patient can also have an accessory right hepatic artery, which indicates the presence of the extra right hepatic artery together with the native right hepatic artery. The replaced left hepatic artery is uncommon, and it arises from the left gastric artery.[10][11]
The neck of the pancreas lies behind the portal vein confluence and is also the origin of the superior mesenteric artery(SMA). SMV located to the right of SMA; thus, SMV is the first vascular structure that one will encounter in the duodenal curvature. In the Cattell-Braasch maneuver, where the right-sided viscera is rotated to the left, the critical structure is inferior vena cava(IVC) and abdominal aorta. The left renal vein crossing across the aorta to drain into IVC is a crucial anatomical observation. The tortuous splenic artery runs along the superior border of the pancreas. The splenic vein runs posteriorly to the body of the pancreas.
The contraindication for the procedure depends on the presence of variable factors. To better understand the contraindications, it is equally important to understand the resectability criteria. Classically, the three grades of resectability are defined for localized pancreatic ductal adenocarcinoma as resectable, borderline resectable, and unresectable.
A- Localized and Resectable
No distant metastasis, no radiographic evidence of portal vein (PV) or superior mesenteric vein (SMV) distortion, clear dissection planes around the celiac axis, hepatic artery, and superior mesenteric artery (SMA)
B- Borderline Resectable
SMV-PV involvement with distortion, narrowing, occlusion, but the presence of suitable proximal and distal vessels for reconstruction. Gastroduodenal artery encasement up to the hepatic artery with short segment encasement or abutment of the hepatic artery without extending to the celiac axis. Tumor abutment of superior mesenteric artery not extending more than 180 degrees of the vessel wall circumference.[21][22]
C- Unresectable for Cancer of the Head (Contraindication of the Procedure)
The surgeon and the instrument nurse stand on the right side of the patient. The first assistant is on the left side of the patient.
Pancreaticoduodenectomy (PD) is performed using vertical midline incision or with a bilateral subcostal incision. A self-retaining retractor is applied. The first step of pancreaticoduodenectomy is a thorough assessment of the extent of disease to determine the resectability. Staging laparoscopy is currently widely used to determine the resectability, and it either could be done as a separate procedure or performed together with PD. The entire liver is assessed and palpated for the possible presence of metastases. Any suspicious findings on the liver but indeterminate on palpation could be evaluated by intraoperative ultrasound. The parietal and visceral peritoneal surfaces, the ligament of Treitz, the omentum, and the entire small and large intestine are examined for the presence of metastasis. The celiac axis is inspected for lymph node involvement. Any suspicious looking lymph nodes outside the planned field of dissection are sent for frozen section. PD is not performed if the biopsy is positive for metastatic cancer. The porta hepatis is inspected by mobilizing the gallbladder and dissecting the cystic duct down to the junction of the common hepatic and common bile duct. The proper hepatic artery and common hepatic artery are assessed for any presence of tumor tissue.
Kocher maneuver is performed by elevating the duodenum and head of the pancreas out of the retroperitoneum. Cattell-Braasch maneuver (extensive mobilization of the entire right colon and small bowel mesentery) is usually not necessary except for mobilization and resection of SMV or if the tumor extends into the 4th part of duodenum.[23]
The gallbladder dissected from the liver, and the distal common hepatic duct is divided close to the level of the cystic duct entry site. The proximal bile duct is left without a clamp to avoid crush injury, and the distal bile duct is clamped or sutured to prevent the spillage of the bile and tumor cells. The bile duct is retracted caudally, and portal dissection continued at the anterior aspect of the portal vein. During these maneuvers, the portal structures should be assessed for a replaced right hepatic artery and should be protected. If the patient appears to have an accessory right hepatic artery and a significant native right hepatic artery, the accessory vessel can often be taken without consequence. The gastroduodenal artery is ligated to minimize the chance of erosion and bleeding. The division of the gastroduodenal artery also helps to expose the anterior surface of the portal vein and facilitates the dissection of the portal vein behind the pancreatic neck. The surgeon identifies the portal vein above the neck of the pancreas and SMV inferior to the neck of the pancreas. Blunt dissection downwards along the portal vein is aimed to create a plane in front of the portal vein and behind the neck of the pancreas. This plane is crucial in the surgery, and if one is unable to create a clear plane between the portal vein and the neck of the pancreas, the surgery should be aborted.
Extensive Kocher maneuver should reveal the SMV inferior to the neck of the pancreas. The superior mesenteric vein runs anterior to the third part of the duodenum and surrounded by adipose tissue as it receives tributaries from the uncinate process and neck of the pancreas, the greater curve of the stomach, and from the transverse mesocolon. Two ways of identifying the superior mesenteric vein are by following the middle colic veins to their juncture with the superior mesenteric vein or by tracing the course of the right gastroepiploic vein to the point at which it meets the superior mesenteric vein immediately below the inferior border of the pancreas. The plane anterior to the superior mesenteric vein is created under direct vision, and the splenic vein is preserved. The junction between the PV and SMV should be clearly visualized.
The vascular resection is performed if necessary. The segmental resection of the portal vein or superior mesenteric vein is usually done with the help of vascular surgeons. The vascular defect can be closed with primary repair, patch closure, or using an autologous graft (internal jugular vein, left renal vein, splenic vein, or greater saphenous vein) or with a synthetic graft (PTFE). The reconstructed portal vein should be followed up regularly postoperative for the risk of portal vein thrombosis.
For the Whipple procedure, antrectomy is performed by dividing the right gastric and right gastroepiploic arteries and dividing the antrum with a linear stapler. The pylorus is preserved in a pylorus-preserving pancreaticoduodenectomy in which the proximal GI tract is divided 2 to 3 cm distal to the pylorus with a linear stapling device. The jejunum is divided between 15 to 20 cm distal to the ligament of Treitz and brought in dorsal to the superior mesenteric vessels from the left to the right side. A Penrose drain is looped under the neck of the pancreas in the created tunnel to elevate the neck of the pancreas and protect the underlying portal vein. The pancreatic neck is then divided using electrocautery after confirming a free plane anterior to the portal and superior mesenteric veins. Stay sutures are placed superiorly and inferiorly on the pancreatic remnant to reduce bleeding from the segmental pancreatic arteries running in those locations.
The specimen remains only connected by the uncinate process of the pancreas. It is separated from the portal vein, superior mesenteric vein, and superior mesenteric artery. This is performed by serially clamping, dividing, and tying the smaller branches off the portal and superior mesenteric vessels. The specimen is removed en-bloc with the pancreatic neck margin, uncinate margin, and common hepatic duct margins are marked for the pathologists. The common hepatic duct margin and the pancreatic neck margin are essential and may be sent earlier for frozen section analysis to determine the extent of further resection. After the removal of the specimen, metal clips are placed at the margins of the resection field to target postoperative radiation therapy. There are various methods available for reconstruction after pancreaticoduodenectomy. Standard reconstruction involves the pancreatic anastomosis (PA) first, followed by the bile duct, and finally, the duodenum to establish the GI continuity.
PA is the most critical step in pancreaticoduodenectomy and meticulous care given during this procedure to reduce morbidity. Either jejunum or stomach can be used for the reconstruction of the pancreatic anastomosis. There are two ways of constructing PA: duct to mucosa anastomosis or invagination technique. For the pancreaticojejunostomy, the duct to mucosa anastomosis is constructed between the end of the pancreatic duct remnant and side of jejunum in a retrocolic fashion. For the invagination technique, the pancreatic duct is junked into the jejunum. The techniques of pancreaticojejunostomy are diverse such as modified Blumgart, modified Kakita, binding pancreaticojejunostomy anastomosis, and so one. The variety of these techniques help to improve the rate of pancreatic fistula formation, but there is no single superior technique.[24] The reconstruction is then followed by end-to-side hepaticojejunostomy, which is performed 10 to 15 cm distal to pancreaticojejunostomy with interrupted single layer synthetic absorbable suture. The third anastomosis performed is the gastrojejunostomy in patients who have undergone classic pancreaticoduodenectomy with distal gastrectomy or duodenojejunostomy in cases of pylorus preservation. This anastomosis is typically performed 10 to 15 cm downstream from the hepaticojejunostomy, proximal to the jejunum traversing the defect in the mesocolon.
After the reconstruction is completed, closed suction drains are placed at Morrison pouch and in the vicinity of the pancreatic and biliary anastomosis. A feeding jejunostomy is usually not needed and depends on the surgeon’s preference. The postoperative management includes keeping the patient with nothing by mouth for day 1 and advancing with clear liquids and then gradually to a low-fat diet in frequent small feeds. The stomach is decompressed overnight after surgery with a nasogastric tube, which is usually removed the next morning if there is no high output. The drains are removed gradually once the output is minimal, there is no evidence of pancreatic fistula, and the patient is tolerating a normal diet.
Pancreatic cancer is the fourth common cause of cancer death, and its 5-year survival rate is only about 12 percent despite the advancement in medical care, chemotherapy, radiotherapy, and molecular biology.[30][31] The pancreaticoduodenectomy is the only curative treatment. The late diagnosis of cancer because of the lack of concrete symptoms makes this cancer as one of lethal cancer. There is an urgent need to find diagnostic markers to detect pancreatic cancer in the early stage.
The morbidity and mortality associated with pancreaticoduodenectomy and its complications are high. Due to the high morbidity associated with this procedure, a more vigilant postoperative care becomes imperative. High suspicion and early detection of the postoperative complication is the critical factor in the care of the patient. Physicians, nurses, and the entire team should be adequately educated, and the organized team approach for patient care must be implemented.
The involvement of an interprofessional team in the management of cancer patients is of the essence, and pancreatic cancer is no exception. The success of pancreaticoduodenectomy depends on a meticulous selection of surgical patients for resectability using a CT of the abdomen with the pancreas protocol. The nurses, physiotherapists, counselors, oncologists play a crucial role in delivering optimum care to the cancer patient.
Dietary assessment and artificial enzyme replacement therapy should be the standard of care in surgical patients. If left untreated exocrine insufficiency results in severe nutritional deficit. Whenever possible, enteral nutrition is preferred over parenteral. Patients should be monitored to assess pancreatic insufficiency, either endocrine or exocrine. Fecal elastase-1 is a rapid test to detect exocrine insufficiency but it has a low sensitivity and specificity.[32]
Nurse care is directed to the proper assessment of weight, general pain, and symptoms, vital signs. The patient must be monitored for weight loss, liquid balance, nausea, fecal, and urine color. Due to the forced loss of pancreatic enzymes, it is crucial to evaluate the presence of fatty stools to ensure proper adjustment of lipidic intake together. A medical-nursing team should ensure a proper evaluation of dietary balance before and after surgical treatment.[33][34]
[1] | Jiang YL,Zhang RC,Zhou YC, Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. BMC cancer. 2019 Aug 7 [PubMed PMID: 31391085] |
[2] | Are C,Dhir M,Ravipati L, History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2011 Jun; [PubMed PMID: 21609369] |
[3] | Schnelldorfer T,Adams DB,Warshaw AL,Lillemoe KD,Sarr MG, Forgotten pioneers of pancreatic surgery: beyond the favorite few. Annals of surgery. 2008 Jan; [PubMed PMID: 18156940] |
[4] | Birkmeyer JD,Siewers AE,Finlayson EV,Stukel TA,Lucas FL,Batista I,Welch HG,Wennberg DE, Hospital volume and surgical mortality in the United States. The New England journal of medicine. 2002 Apr 11; [PubMed PMID: 11948273] |
[5] | Gagner M,Pomp A, Laparoscopic pylorus-preserving pancreatoduodenectomy. Surgical endoscopy. 1994 May [PubMed PMID: 7915434] |
[6] | Asbun HJ,Stauffer JA, Laparoscopic vs open pancreaticoduodenectomy: overall outcomes and severity of complications using the Accordion Severity Grading System. Journal of the American College of Surgeons. 2012 Dec [PubMed PMID: 22999327] |
[7] | Conrad C,Basso V,Passot G,Zorzi D,Li L,Chen HC,Fuks D,Gayet B, Comparable long-term oncologic outcomes of laparoscopic versus open pancreaticoduodenectomy for adenocarcinoma: a propensity score weighting analysis. Surgical endoscopy. 2017 Oct [PubMed PMID: 28205031] |
[8] | O'Sullivan AW,Heaton N,Rela M, Cancer of the uncinate process of the pancreas: surgical anatomy and clinicopathological features. Hepatobiliary [PubMed PMID: 20007071] |
[9] | Liu C,Tian X,Xie X,Gao H,Zhuang Y,Yang Y, Comparison of Uncinate Process Cancer and Non-Uncinate Process Pancreatic Head Cancer. Journal of Cancer. 2016; [PubMed PMID: 27390599] |
[10] | Covey AM,Brody LA,Maluccio MA,Getrajdman GI,Brown KT, Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology. 2002 Aug; [PubMed PMID: 12147854] |
[11] | Rubio-Manzanares-Dorado M,Marín-Gómez LM,Aparicio-Sánchez D,Suárez-Artacho G,Bellido C,Álamo JM,Serrano-Díaz-Canedo J,Padillo-Ruiz FJ,Gómez-Bravo MÁ, Implication of the presence of a variant hepatic artery during the Whipple procedure. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2015 Jul; [PubMed PMID: 26140634] |
[12] | Liang B,Chen Y,Li M,Dong X,Yao S,Liu T, Total laparoscopic duodenum-preserving pancreatic head resection for solid pseudopaillary neoplasm of pancreas: A case report. Medicine. 2019 May [PubMed PMID: 31124984] |
[13] | Kim H,Song KB,Hwang DW,Lee JH,Alshammary S,Kim SC, Laparoscopic versus open pancreaticoduodenectomy for pancreatic neuroendocrine tumors: a single-center experience. Surgical endoscopy. 2019 Dec [PubMed PMID: 31300907] |
[14] | Zhou Y,Wang X,Si X,Wang S,Cai Z, Surgery for duodenal gastrointestinal stromal tumor: A systematic review and meta-analysis of pancreaticoduodenectomy versus local resection. Asian journal of surgery. 2020 Jan [PubMed PMID: 30853211] |
[15] | Hüttner FJ,Capdeville L,Pianka F,Ulrich A,Hackert T,Büchler MW,Probst P,Diener MK, Systematic review of the quantity and quality of randomized clinical trials in pancreatic surgery. The British journal of surgery. 2019 Jan [PubMed PMID: 30582642] |
[16] | Babiker HM,Kashyap S,Recio-Boiles A, Cancer, Mucinous Cystic Pancreatic Neoplasms . 2020 Jan [PubMed PMID: 28846358] |
[17] | Morales E,Zimmitti G,Codignola C,Manzoni A,Garatti M,Sega V,Rosso E, Follow "the superior mesenteric artery": laparoscopic approach for total mesopancreas excision during pancreaticoduodenectomy. Surgical endoscopy. 2019 Dec [PubMed PMID: 31332566] |
[18] | Yoshimachi S,Ohtsuka H,Aoki T,Miura T,Ariake K,Masuda K,Ishida M,Mizuma M,Hayashi H,Nakagawa K,Morikawa T,Motoi F,Kanno A,Masamune A,Fujishima F,Sasano H,Kamei T,Naitoh T,Unno M, Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: a case report and literature review. Clinical journal of gastroenterology. 2020 Feb [PubMed PMID: 31342462] |
[19] | Mikulić D,Bubalo T,Mrzljak A,Škrtić A,Jadrijević S,Kanižaj TF,Kocman B, Role of total pancreatectomy in the treatment of paraduodenal pancreatitis: A case report. World journal of gastrointestinal surgery. 2019 Jun 27 [PubMed PMID: 31367277] |
[20] | Rios G,Conrad A,Cole D,Adams D,Leveen M,O'Brien P,Baron P, Trends in indications and outcomes in the Whipple procedure over a 40-year period. The American surgeon. 1999 Sep [PubMed PMID: 10484097] |
[21] | Tempero MA,Malafa MP,Al-Hawary M,Asbun H,Bain A,Behrman SW,Benson AB 3rd,Binder E,Cardin DB,Cha C,Chiorean EG,Chung V,Czito B,Dillhoff M,Dotan E,Ferrone CR,Hardacre J,Hawkins WG,Herman J,Ko AH,Komanduri S,Koong A,LoConte N,Lowy AM,Moravek C,Nakakura EK,O'Reilly EM,Obando J,Reddy S,Scaife C,Thayer S,Weekes CD,Wolff RA,Wolpin BM,Burns J,Darlow S, Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2017 Aug; [PubMed PMID: 28784865] |
[22] | Mullapudi B,Hawkes PJ,Patel A,Are C,Misra S, Borderline resectable pancreatic cancer. Indian journal of surgical oncology. 2015 Mar [PubMed PMID: 25937766] |
[23] | Warshaw AL,Thayer SP, Pancreaticoduodenectomy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2004 Sep-Oct; [PubMed PMID: 15358336] |
[24] | Berger AC,Howard TJ,Kennedy EP,Sauter PK,Bower-Cherry M,Dutkevitch S,Hyslop T,Schmidt CM,Rosato EL,Lavu H,Nakeeb A,Pitt HA,Lillemoe KD,Yeo CJ, Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. Journal of the American College of Surgeons. 2009 May; [PubMed PMID: 19476827] |
[25] | Navez J,Hubert C,Dokmak S,Frick De La Maza I,Tabchouri N,Benoit O,Hermand H,Zech F,Gigot JF,Sauvanet A, Early Versus Late Oral Refeeding After Pancreaticoduodenectomy for Malignancy: a Comparative Belgian-French Study in Two Tertiary Centers. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2019 Jul 19 [PubMed PMID: 31325133] |
[26] | Bassi C,Dervenis C,Butturini G,Fingerhut A,Yeo C,Izbicki J,Neoptolemos J,Sarr M,Traverso W,Buchler M, Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005 Jul; [PubMed PMID: 16003309] |
[27] | Feng F,Cao X,Liu X,Qin J,Xing Z,Duan J,Liu C,Liu J, Two forms of one complication: Late erosive and nonerosive postpancreatectomy hemorrhage following laparoscopic pancreaticoduodenectomy. Medicine. 2019 Jul [PubMed PMID: 31348239] |
[28] | Kato H,Iizawa Y,Nakamura K,Gyoten K,Hayasaki A,Fujii T,Murata Y,Tanemura A,Kuriyama N,Azumi Y,Kishiwada M,Mizuo S,Usui M,Sakurai H,Isaji S, The Critical Role of Biliary Candidiasis in Development of Surgical Site Infections after Pancreatoduodenectomy: Results of Prospective Study Using a Selective Culture Medium for Candida Species. BioMed research international. 2018 [PubMed PMID: 30581862] |
[29] | Ashitomi Y,Sugawara S,Takahashi R,Ashino K,Watanabe T,Hachiya O,Kimura W, Severe acute pancreatitis 5 years after pancreaticoduodenectomy: A case report. International journal of surgery case reports. 2019 [PubMed PMID: 31357105] |
[30] | Giuliano K,Ejaz A,He J, Technical aspects of pancreaticoduodenectomy and their outcomes. Chinese clinical oncology. 2017 Dec; [PubMed PMID: 29156887] |
[31] | Ferrone CR,Brennan MF,Gonen M,Coit DG,Fong Y,Chung S,Tang L,Klimstra D,Allen PJ, Pancreatic adenocarcinoma: the actual 5-year survivors. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2008 Apr; [PubMed PMID: 18027062] |
[32] | Lim JH,Park JS,Yoon DS, Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2017 May; [PubMed PMID: 28286044] |
[33] | Kim E,Kang JS,Han Y,Kim H,Kwon W,Kim JR,Kim SW,Jang JY, Influence of preoperative nutritional status on clinical outcomes after pancreatoduodenectomy. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2018 Nov; [PubMed PMID: 29887259] |
[34] | Gianotti L,Besselink MG,Sandini M,Hackert T,Conlon K,Gerritsen A,Griffin O,Fingerhut A,Probst P,Abu Hilal M,Marchegiani G,Nappo G,Zerbi A,Amodio A,Perinel J,Adham M,Raimondo M,Asbun HJ,Sato A,Takaori K,Shrikhande SV,Del Chiaro M,Bockhorn M,Izbicki JR,Dervenis C,Charnley RM,Martignoni ME,Friess H,de Pretis N,Radenkovic D,Montorsi M,Sarr MG,Vollmer CM,Frulloni L,Büchler MW,Bassi C, Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2018 Nov; [PubMed PMID: 30029989] |